$3.38
-0.87-20.47%
Last update: Nov 10, 7:22 PM
P3 Health Partners Inc
PIIINASDAQ
P3 Health Partners fell 42.3% from $7.36 to $4.25, behind the S&P 500's +10.0%. Its worst day was May 29 (−26.0%), and its low came Feb 2 at $1.56.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-9.67 missed the $-7.10 estimate on $345.3M revenue (est. $350.3M); FY revenue guidance of $1.4B–$1.4B against the $1.4B consensus.
−5.1% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
P3 Health Partners closed at its lowest level of the year, 78.8% below where the year started.
−18.7% · S&P 500 +0.5%
EPS of $-23.02 missed the $-8.16 estimate on $384.8M revenue (est. $357.6M); FY revenue guidance of $1.5B–$1.7B against the $1.6B consensus.
+5.4% · S&P 500 −1.7%
EPS of $-1.72 beat the $-3.28 estimate on $386.4M revenue (est. $391.5M); FY revenue guidance of $1.5B–$1.6B against the $1.5B consensus.
+180.1%, the year's best day, on 66M shares, the year's heaviest volume · S&P 500 −1.2%
P3 Health Partners closed at its highest level of the year, 123.8% above where the year started.
+3.4% · S&P 500 +0.6%
EPS of $-0.63 beat the $-1.90 estimate on $386.4M revenue (est. $377.8M); FY revenue guidance of $1.5B–$1.6B against the $1.5B consensus.
−3.6% · S&P 500 −0.3%
Where it ended: a close of $4.25 on Nov 9, 2026.
Nothing in the past 12 months.
All PIII dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PIII and SPY from Benzinga historical bars. Not investment advice.
